Enlivex Therapeutics Ltd.

1.76 USD
-0.01 (-0.56%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Enlivex Therapeutics Ltd. stock is down -9.74% since 30 days ago. The next earnings date is Dec 19, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 10% of the previous 9 December’s closed higher than November.

About Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state.